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Objective Quantification of Posterior Capsule
Opacification after Cataract Surgery, with Optical
Coherence Tomography
Javier Moreno-Montan˜e´s, Aurora Alvarez, and Miguel J. Maldonado
PURPOSE. To evaluate posterior capsule opacification (PCO) in
humans after cataract surgery with intraocular lens (IOL) im-
plantation, by using optical coherence tomography (OCT-1).
METHODS. Sixty-six eyes with PCO and 20 eyes with a normal
posterior capsule were analyzed. A 3-mm-long horizontal scan
of the posterior capsule was obtained. Measurements at three
points and their average were recorded. Intraoperator and
interoperator reliabilities were assessed. Investigated was peak
intensity (PI) and posterior capsule thickening (PCT), with PCT
indicating the distance between two reflectivity spikes, with an
approximate axial resolution of 10 m. Results were compared
with visual acuity (VA) and PCO type.
RESULTS. Intraoperator reliability was 0.59 and 0.97 for average
PI and PCT, respectively. The interoperator concordance cor-
relation coefficient was 0.70 and 0.82 for average PI and PCT,
respectively. Median (interquartile range) intensities of the
reflectivity spike were 16.88 (dB) (range, 12.88–20.41) and
11.9 (8.58–14.28), respectively, in the PCO and control eyes (P
 0.001). PCT was found in PCO eyes (median: 86.13 m;
range, 46.33–115.33), whereas no second spike appeared in
control eyes (P  0.001). The area under the receiver operat-
ing characteristic curve of the average PCT for differentiating
pearl-type from fibrosis-type PCO was 0.87 (P  0.001). For a
cutoff point of 55.3 m, the sensitivity was 97.5%, and the
specificity was 69%. Worse VA correlated significantly only
with larger PCT (ro 0.66; P  0.01).
CONCLUSIONS. OCT-1 appears useful to quantitate PCO. In addi-
tion, this system seems to discriminate between different types
of PCO. PCT may be a previously unrecognized factor in VA
degradation. (Invest Ophthalmol Vis Sci. 2005;46:3999–4006)
DOI:10.1167/iovs.04-1531
Posterior capsule opacification (PCO), the most commonlong-term complication of cataract surgery, is caused by
lens epithelial cells that remain in the capsular bag after sur-
gery. The cells migrate, proliferate, and transform, to produce
Elschnig’s pearls and capsular fibrosis.1 These processes do not
cause symptoms in the peripheral capsular bag, but encroach-
ment onto the visual axis causes light-scattering and visual
deterioration. PCO can be treated by Nd:YAG laser capsulot-
omy; however, complications such as cystoid macular edema
and retinal detachment may develop and the visualization of
the peripheral retina does not improve. In addition, the cost of
the cataract surgery increases.
Although the incidence of PCO has decreased because of
improved surgical and cortical cleanup techniques, it is still
considerable and varies greatly among studies.2–9 Cataract ex-
tractions are performed on more than 1 million patients annu-
ally in the United States, at least a quarter of whom eventually
have PCO.10,11
Optical coherence tomography (OCT) facilitates high-reso-
lution cross-sectional imaging of tissue in which optical inter-
ferometry determines the distance to reflective ocular struc-
tures.12 OCT has been studied extensively for qualitative and
quantitative analysis of retinal disease13 and nerve fiber layer
thickness measurements.14 In both modalities, OCT has dem-
onstrated adequate reproducibility. Other applications of OCT
in the anterior segment also have been reported. In our previ-
ous study,15 OCT was useful for evaluating the qualitative and
quantitative anatomic outcomes after LASIK. We also demon-
strated excellent reproducibility of repeated pachymetric OCT
measurements.15 OCT can be used to analyze other anterior
segment features.16–18
The purpose of the present study was to assess PCO using
OCT as a noncontact imaging and high-resolution tool to eval-
uate the efficacy of the procedure for quantifying PCO and its
characteristics.
PATIENTS AND METHODS
Patient Selection
We conducted a study using OCT-1 in patients with PCO in the visual
axis after cataract surgery. This study was performed over 6 months
and included all patients with biomicroscopically detectable PCO that
we examined during this period. The control group comprised pa-
tients without PCO who were examined during the same period. We
excluded patients with active ocular disease or IOL displacement,
those who had had a YAG laser posterior capsulotomy, and those who
had difficulty with ocular fixation with OCT-1. Patients with an anterior
capsulotomy other than capsulorrhexis or cases without overlapping
of the capsulorrhexis rim over the anterior optic IOL surface were also
excluded.
Sixty-six eyes (56 patients) with the biomicroscopic finding of PCO
were included. The patients ranged in age from 18 to 86 years (median
age, 71.50 years; interquartile range [IR], 64.75–76 years); 21 were
men (median age, 72 years; IR, 65–77 years) and 35 were women
(median age, 69 years; IR, 64–76 years; P 0.57; men versus women).
Twenty eyes of 20 consecutive patients (10 men, 10 women)
served as the control. These patients had undergone phacoemulsifica-
tion at our institution without development of biomicroscopically
detectable PCO or other complications. All control eyes underwent the
same examination as the patients with PCO. Inclusion criteria were
Snellen best-corrected visual acuity (BCVA) of 20/20 and myopia or
hyperopia less than 4 D. If the patients had undergone bilateral cataract
surgery, only one eye was randomly included in the control group. The
median age of the control group was 76 years (IR, 69.75–77.75; P 
0.01 compared with the PCO group by the Mann–Whitney test). All
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patients provided written informed consent. The clinical research
committee of our institution approved the study protocol.
Patient Examination
All eyes underwent a complete ophthalmic evaluation that included
measurement of BCVA, anterior segment biomicroscopy with PCO
evaluation (fibrosis-type or pearl-type),19,20 and macular visualization
with indirect ophthalmoscopy. BCVA was converted to the logarithm
of the minimum angle of resolution (logMAR) scale. All patients were
examined by one clinician (JM-M). One drop of phenylephrine and
tropicamide was instilled to induce mydriasis before OCT.
To compare OCT results with the data from the cataract surgery,
we reviewed the patients’ charts, and the type of IOL implanted was
documented. The months between cataract surgery and evaluation of
PCO were calculated.
OCT Examination
The principles and optical properties of the OCT system have been
described previously.21,22 The OCT-1 scanner (Carl Zeiss Meditec,
Dublin, CA) with the A-4 software update was used throughout the
study. After the pupil was dilated to 4 mm, PCO was measured with the
scan profile display. After ensuring central fixation, a 3-mm-long hori-
zontal scan was obtained from the IOL surface and the posterior
capsule at the center of the IOL (Fig. 1). Three measurements of each
scan were taken: at the center of the scan (fixation point) and 800 m
temporal (temporal point) and 800 m nasal (nasal point) to the
fixation. The acquisition process was improved by changing some
parameters on the control console (noise threshold level was set at
0.06 V, and the z-offset and polarization controls were adjusted for
each scan). Because the posterior capsule thickness varies from 4 to 9
m in the normal human eye,23 our system could detect only a
posterior capsule thickening (PCT) when total posterior capsule thick-
ness exceeded 10 m (the axial resolution of OCT) in a single mea-
surement of the capsule thickness in each patient. PCT was therefore
detected when two reflectivity spikes appeared behind the reflectivity
corresponding to the IOL. Computer software-controlled cursors were
manually placed at the peak of the reflectivity spikes corresponding to
the posterior capsule, and tissue thickening was calculated between
the peaks from the time delay of the reflected light. Computer cursors
placed at the peak of the reflectivity spikes yielded better reproduc-
ibility than placing the cursors at the beginning of the rising slopes. In
addition, the peak intensities (i.e., the maximum height of the spikes in
decibels), were measured at the most posterior spike of the PCO. The
same assistant research technician (AA), who had extensive experi-
ence with this technique15,24 performed all measurements.
Reliability Study
A subset of 30 eyes of 30 patients underwent repeated measurements,
to assess the reliability of the procedure. Intraoperator repeatability
was calculated after our experienced examiner acquired and analyzed
two consecutive examinations from the same eye in the same session.
Interoperator repeatability was assessed after the first examination
obtained by our experienced examiner (operator 1 [AA]) was com-
pared with the one acquired and analyzed from the same eye in the
same session by another independent masked examiner (operator 2).
Between examinations, the subject was separated from the device, and
the operator left the room, so that the operator had to reposition the
subject before taking another examination.
The study protocol adhered to the tenets of the Declaration of
Helsinki. Participants provided written informed consent.
Statistical Analysis
Data forms were completed with the OCT values quantified at the
center, nasal, and temporal locations. In addition, the averages of all
three were computed. Analyses were performed on computer (SPSS,
ver. 11.0; SPSS, Inc., Chicago, IL). The statistical significance was
determined by the Kruskal-Wallis test, and the Mann-Whitney nonpara-
metric test provided the nonparametric data distribution. Results are
expressed as medians and interquartile ranges. Associations among
study variables were analyzed by calculating the Spearman correlation
coefficient.
Intraoperator repeatability was calculated as 2.77 times the within-
subject SD (sw) of the two consecutive measurements for each eye.25
The difference between two measurements for the same subject is
expected to be 2.77  sw for 95% of pairs of observations.25 The
TABLE 1. Intraoperator Repeatability and Reliability
OCT Estimates Repeatability*
Reliability†
(95% CI)
Peak intensity (dB)
Temporal 7.80 0.29 (0.08–0.59)
Nasal 5.37 0.75 (0.53–0.87)
Center 9.99 0.06 (0.31–0.42)
Average 5.1 0.59 (0.3–0.78)
Posterior capsule
thickening (m)
Temporal 27.26 0.96 (0.92–0.98)
Nasal 16.16 0.97 (0.95–0.99)
Center 37.87 0.88 (0.77–0.94)
Average 19.79 0.97 (0.93–0.98)
* Intraoperator repeatability was calculated as 2.77 times the with-
in-subject standard deviation of the two consecutive measurements for
each eye.25
† Reliability is calculated with the intraclass correlation coefficient
(ICC).26
TABLE 2. Interoperator Repeatability
OCT Estimates
P
(t-test)
Mean
Difference*
Limits of
Agreement
Lower Upper
Peak intensity (dB)
Temporal 0.341 1.22 14.06 11.61
Nasal 0.096 2.24 11.50 15.98
Center 0.093 1.11 5.77 7.99
Average 0.115 0.74 4.18 5.67
Posterior capsule
thickening (m)
Temporal 0.263 5.33 43.13 53.79
Nasal 0.084 11.14 55.86 78.13
Center 0.225 7.14 69.13 54.85
Average 0.503 2.74 40.68 46.16
* Mean difference between examiners.
FIGURE 1. The location of the OCT scan is shown (horizontal, light
area). The portion of the central posterior capsule that is tomographi-
cally imaged measures an average of 3 mm long and is located over the
visual axis.
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intraoperator reliability of the measurement method was also calcu-
lated with the intraclass correlation coefficient (ICC).26
The 95% limits of agreement (LoA) were calculated as the average
difference in measurements made by the two examiners1.96 SD, the
lower values indicating higher interoperator repeatability.27 The paired
t-test was also used to establish whether there was any statistically
significant systematic bias between measurements made by different
examiners. The interoperator reliability of the measurement method
was calculated with the concordance correlation coefficient described
by Lin.28
The ability of the four PCT estimates to discriminate between
pearl-type and fibrosis-type PCO was investigated with receiver oper-
ating characteristic (ROC) curves.29 Optimal cutoff levels for pearl-type
PCO detection were determined using Youden’s index (  sensitivity
 specificity  1).30,31 All statistical tests were two-tailed, and  was
set at 0.05.
FIGURE 2. PCO types. (A) Anterior
and posterior IOL surfaces and pos-
terior capsule in the control group.
(B) Slit-lamp image of a silicone IOL
in the control group. (C) OCT image
of fibrosis-type PCO. (D) Slit-lamp im-
age of fibrosis-type PCO. (E) OCT
image obtained in a case with pearl-
type PCO with a posterior concave
PMMA IOL in high myopia. A gap
between the posterior surface of the
IOL and the posterior capsule can be
seen (double-headed arrow). The
pearl-type PCO and its increased
thickness are shown. (F) Slit-lamp im-
age of the posterior capsule with
pearl-type PCO.
TABLE 3. Interoperator Concordance
OCT Estimates CCC* (95% CI)
Peak intensity (dB)
Temporal 0.29 (0.02–0.52)
Nasal 0.24 (0.03–0.48)
Center 0.56 (0.26–0.76)
Average 0.70 (0.46–0.84)
Posterior capsule thickening (m)
Temporal 0.79 (0.60–0.90)
Nasal 0.58 (0.32–0.75)
Center 0.72 (0.49–0.85)
Average 0.82 (0.65–0.91)
* Lin’s concordance correlation coefficient (CCC).28
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RESULTS
Reliability Study
Intraoperator repeatability was 5.1 dB and 19.8 m for the
average peak intensity and PCT, respectively. Table 1 shows
that the average and nasal values were more repeatable inter-
nally than the central and temporal measurements for both
peak intensity and PCT. Also, intraoperator reliability (ICC)
was overall better for PCT measurements than for peak inten-
sity values.
No statistically significant difference was found between
both examiners’ readings for both peak intensity and PCT
(Table 2). LoA were moderate to wide and generally larger for
point estimates than for the average of the three locations
(Table 2). Concordance correlation coefficients indicated that
interoperator reproducibility was generally better for PCT mea-
surements than for peak intensity values (Table 3).
Clinical Study
Of the 66 eyes with PCO, 26 (39.4%) had fibrosis-type PCO and
40 (60.6%) had pearl-type PCO. The logMAR-BCVA of eyes with
PCO (median, 0.39; IR, 0.22–0.69) was significantly worse
than that in the control group (P  0.001). In cases with
fibrosis-type PCO, the logMAR-BCVA median was 0.3 (IR, 0.22–
0.39) and in cases with the pearl PCO, the median was 0.39
(IR, 0.22–0.79; P  0.21). The median of time after surgery
FIGURE 3. OCT peaks obtained in
the same eyes as in Figure 2. (A) The
anterior and posterior IOL peaks are
shown in an eye without PCO. (B)
The cursor 3 value (8.7 dB), indicates
the peak intensity at the posterior
capsule. (C) Scan profile in an eye
with fibrosis-type PCO. The peaks
corresponding to the anterior and
posterior IOL surfaces are shown. In
addition, the distance between the
second and third peak is considered
to be the PCT. (D) The distance be-
tween cursors 1 and 2 is used to
measure PCT (84 m). The cursor 3
indicates the peak intensity value
(16.3 dB). (E) This scan profile
shows four major peaks: the first two
correspond to the anterior and pos-
terior IOL surfaces, respectively. The
distance between the second and
third peaks shows the gap between
the IOL and the posterior capsule.
More posteriorly, a number of peaks
reflect PCO. (F) The cursors are
placed on the first and the last peaks
of the PCO. The distance between
cursors 1 and 2 is 216 m (PCT). The
cursor 3 indicates the peak intensity
value of the last PCO peak (20.6 dB).
TABLE 4. Comparison of Intensity Peaks of the Posterior Capsule among the Groups
Group Eyes (n) Temporal Center Nasal Average
Control 20 11.85 (8.9–18.47) 11 (9.7–13.9) 9.3 (7.75–11.92) 11.9 (8.58–14.28)
Fibrosis-type 26 17.5 (12.75–22.9) 16.1 (11.9–20.65) 15.5 (10.1–19.85) 16.98 (13–20.04)
Pearl-type 40 17 (11.75–18.90) 17.9 (12.2–23) 15.5 (10.6–19.8) 16.85 (12.75–20.52)
P * 0.59 0.41 0.95 0.86
Data are expressed as median decibels (interquartile range).
* Comparison between groups with the fibrosis-type and pearl-type PCO (Mann-Whitney test).
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was 36 months (IR, 23–47.25) in eyes with PCO and 23
months (IR, 3.25–58.75) in the control group (P  0.19).
Images obtained from the groups based on opacification
type are shown in Figures 2 and 3. The median intensities of
the reflectivity spikes were 16.88 dB (IR, 12.88– 20.41) in PCO
eyes and 11.9 dB (IR, 8.58–14.28) in the control group (P 
0.001). The average PCO intensities at the three measurement
points are shown in Table 4. No significant differences in the
three points and the average intensities were found when the
two PCO types were compared.
PCT could not be measured in control eyes, because only
one peak occurred. In the PCO group, the median PCT was
83.16 m (IR, 46.33–115.33; P  0.001 compared with the
control group). There was a significant difference (P  0.001)
in the PCT between the groups with the fibrosis-type and the
pearl-type PCO (Table 5).
The correlation between BCVA and PCT (Fig. 4) was statis-
tically significant (ro  0.66; 95% CI, 0.51–0.76; P  0.001).
No significant relationship was obtained between BCVA and
PCO intensity (ro  0.1; 95% CI, 0.34 to 0.15; P  0.42; Fig.
5). Time after surgery did not correlate with either PCT (ro 
0.22; 95% CI, 0.44 to 0.03; P  0.08), PCO intensity (ro
0.13; 95% CI, 0.12 to 0.37; P  0.30), or BCVA (ro 
0.16; 95% CI, 0.40 to 0.09; P  0.21; Fig. 6).
Classification accuracy for pearl-type PCO as opposed to
fibrosis-type PCO is shown in Table 6. The average PCT had
the ROC curve with the highest diagnostic value and repre-
sents the best discriminator between pearl-type and fibrosis-
type PCO (Fig. 7). Its AUC was 0.872. The maximum
Youden’s index of average PCT was 0.67 corresponding to a
cutoff level of 55.3 m (Table 7). Sensitivity and specificity
for this cutoff point were 97.5% and 69.2%, respectively.
DISCUSSION
PCO evaluation is important for measuring the effect of IOL
designs or biocompatibility, pharmaceutical treatments, and
variations in cataract surgery techniques. The ideal system of
evaluation should be objective, easy to perform, have minimal
bias, be sufficiently sensitive to calculate small PCO variations,
and produce a quantifiable PCO value that correlates well with
VA changes.32
Different methods of PCO evaluation have been reported
that are either qualitative or quantitative. Qualitative methods,
such as slit lamp grading evaluation and fundus visualization,
can illustrate PCO but are subjective and have difficulty calcu-
lating PCO evolution.32
Recently, new methods of PCO quantitative evaluation
have been reported.12,32–34 No one system is considered a
gold standard, and each has advantages and disadvantages.
Scheimpflug videophotography has been used to provide
reproducible, objective, and quantitative measurements of
PCO that have good correlation with VA.35–37 However, the
intensity of PCO quantified by Scheimpflug videophotogra-
phy cannot be compared with different IOL materials,38 and
this system is not readily available to most eye centers.32
Overall, digital photographic image acquisition systems al-
low access to computerized analysis, which can reduce
observer bias and increase accuracy.32 Brightness-based
analysis, however, is little used because of the abundance
of potential error sources (variations in background inten-
sity and in illumination).32 Computerized analyses of density
boundaries such as the EPCO 2000 (a software program
developed by Manfred Tetz and Christophe Nimsgern,
Universitats-Augenklinik Charite, Berlin, Germany) and the
POCO (posterior capsule opacification) systems analyze a
wide area of the posterior capsule, but appear not to be fully
objective in that they rely on the human operator to assess
the PCO levels in different areas of the digital computer
image.32,39 Texture analysis is regarded to be the nearest to
a fully objective system for analysis.32,40 However, the spe-
cialized equipment is not available for general use.32 The
color-coded grid system is freely available, but appears to be
FIGURE 5. Posterior capsule intensity plotted against best-corrected
visual acuity in logMAR units (Spearman correlation  0.1; n  86).
TABLE 5. Comparison of Posterior Capsule Thickness (m, median and interquartile range)
Group Eyes (n) Temporal Center Nasal Average
Control 20 0 0 0 0
Fibrosis-type 26 38 (27–81) 30 (19–81) 28 (11–85) 34.66 (17.33–74.66)
Pearl-type 40 90 (76–151) 100 (76–152) 98 (72–151) 100.66 (78.66–146)
P * 0.001 0.001 0.001 0.001
Data are expressed as the median micrometers (interquartile range).
* Comparison between groups with fibrosis-type and pearl-type PCO (Mann-Whitney test).
FIGURE 4. Scatterplot of PCT increase versus logMAR best-corrected
visual acuity (Spearman correlation  0.66).
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less objective than the POCO system and has not been
extensively tested in clinical trials.32
In this study, we present a new way to evaluate PCO
using OCT-1. Although OCT is becoming increasingly avail-
able to many eye centers, to the best of our knowledge,
there have been no previous reports using OCT to study
PCO. OCT, which uses a low-coherence light without caus-
ing patient discomfort by flashes of light, provide real-time
imaging of the posterior capsule. Until now, we have been
able to obtain cross-sectional measurements that enable
quantification of PCT using the above-mentioned technique,
which is not completely automated. However, despite not
analyzing a wide area, we found a good correlation of PCO
values with VA, in an analogous way as reported for the
Scheimpflug system,35 and the PCT measurements were
very reliable internally. Previous studies involving OCT also
have shown good reproducibility of retinal and corneal
measurements.15,41,42
Intraoperator repeatability of OCT PCO quantification was
shown in Table 1 to be generally good. It has been recom-
mended that an ICC should exceed 0.90 if a technique is to be
used for individual assessments in clinical practice and 0.70 for
discriminating among groups in research.43 Most PCT esti-
mates qualified therefore for both modalities, however, only
central peak intensity values maybe used, and solely for the
latter.
Although no significant systematic bias was found be-
tween both operators, the limits of agreement tended to
be overall wide and clinically relevant (Table 2). This can be
explained because none of the technicians at our institution
was as experienced using OCT as operator 1.15,24 De-
spite this limitation, Lin’s concordance correlation coeffi-
cient28 indicated good and acceptable interoperator repeat-
ability for the average PCT and peak intensity, respectively
(Table 3).
Two OCT types of measurements were obtained from the
PCO: the intensity of the peaks and the distance between two
peaks at the posterior capsule. To the best of our knowledge,
this is the first time that an objective estimate of PCO thickness
was quantified in living human eyes. With OCT, each reflectiv-
ity peak is created when the tissue structure changes. If only
one peak occurs, the PCO thickness cannot be measured ac-
curately because the OCT resolution (10 m)12,43 exceeds
normal posterior capsule thickness, which ranges from 4 to 9
m and shows no significant changes with age.23 If two peaks
are obtained in the PCO, the first is produced by the reflective
change between the IOL material and the posterior capsule,
and the second results from the reflective change between the
posterior capsule and vitreous. Thus, the distance between the
two peaks can be considered the PCT, given the OCT axial
resolution.12,42
Cheng et al.19 showed that patients with pearl-type PCO
had worse VA and contrast sensitivity than those with fibro-
sis-type PCO. They suggested that the fibrosis-type PCO
attenuates light, whereas the pearl-type PCO primarily
causes light-scattering and superimposes a forward veiling
light on the retina, reducing the contrast of retinal images.
Thus, the more scattered the light, the greater the reduc-
tions in VA and contrast sensitivity.19 Our results indicated
that the BCVA was lower in eyes with the pearl-type PCO
and also that in those eyes the PCO was thicker than in those
with the fibrosis-type PCO. We found a significant relation-
ship between BCVA and PCO thickness, but no correlations
between BCVA and peak intensity or between BCVA and the
time after surgery. These results suggest that PCO thickness
is an important factor that causes decreased VA. This obser-
vation is consistent with the clinical experience in some
eyes in which faint fibrosis is observed immediately after
cataract surgery without a decrease in BCVA. However,
because we did not measure contrast sensitivity, the rela-
tionship between visual function and PCO thickness must be
considered cautiously.
FIGURE 6. Relationship between best-corrected visual acuity (log-
MAR) and the time after cataract surgery (in months). In five cases with
PCO, the patient was operated on elsewhere, and it was impossible to
know the elapsed time after surgery (n  81).
FIGURE 7. ROC for average PCT by OCT used to identify pearl-type
PCO (as opposed to fibrosis-type PCO), n  86.
TABLE 6. Area under the ROC Curve for Differentiating Pearl-Type
from Fibrosis-Type PCO, According to PCT as Measured by OCT
PCT Measure
Area under
ROC Curve 95% CI P*
Central 0.868 0.771–0.964 0.001
Nasal 0.825 0.712–0.938 0.001
Temporal 0.808 0.694–0.922 0.001
Average† 0.872 0.776–0.968 0.001
n  66.
* Statistical significance of the area under the ROC curve.
† Average of the central, nasal, and temporal measures of PCT.
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Because we believe that OCT may play a role in clinical
research, discriminating the two types of PCO by OCT alone
would be interesting, because it would allow technicians to
collect data in large samples of patients for transverse and
longitudinal studies without the need to have an ophthal-
mologist examine each eye. The AUC was then used to
measure diagnostic performance of PCT by OCT in differen-
tiating pearl-type from fibrosis-type PCO. Measurements dis-
criminated fairly well between both PCO types (Table 6).
Overall, the sensitivity was high and specificity was fair for
each of the PCT estimates. Specifically, the average PCT
cutoff value of 55.3 m showed a tolerable balance between
sensitivity and specificity, which make it a useful objective
tool for detecting pearl-type PCO, a relevant aspect given
the meaningful visual and recurrence rate implications of
this type of PCO.19
This study had several limitations. First, the OCT tissue
thickness is calculated between two points from the time-
delay of reflected light by assuming a constant refractive
index of 1.36.13 The fact that the posterior capsule tissue
refractive index is slightly different (1.40)23 from the retinal
refractive index13 may indicate that the measurements are
approximate but not exact. However, for comparison and
objective analysis, OCT appears useful for measuring PCT, as
it has been for measuring corneal thickness.15,44 The peak
intensity was obtained from the second peak, but other
lower peaks inside the PCO thickness were not considered
because of the inherent difficulty in measuring them accu-
rately from the baseline values and the mathematical analysis
of many points. There were a small number of patients with
PCO, because the inclusion criteria were restrictive. In
addition, three points were measured and not the full pos-
terior capsule. However, the three points covered a width of
1.6 mm located centrally. This area, although limited, has
more impact on visual function, and in fact measurements
correlated with VA. Nevertheless, more specific software
that would analyze a wider area is desirable and may become
a reality, as it has with retinal mapping.21 Despite these
limitations, the OCT technique was easy to perform and
noninvasive, allowed quantitative analysis of PCO, especially
of PCT, and the results were consistent with the results of
other methods of PCO evaluation.19,29 For these reasons, we
believe that this study is a valuable contribution to PCO
research.
In summary, OCT-1 produced an objective estimate of
PCO intensity and thickness. The intraoperator repeatability
of the PCO measurements was moderate for peak intensity
estimates and excellent for PCT estimates, which make them
useful for discriminating among groups in research. Inter-
operator repeatability was notably lower, which should be
improved by equaling the experience of different examiners
using OCT for these purposes. This system also discrimi-
nated between pearl-type and fibrosis-type PCO. The rela-
tionship between the BCVA and the PCT suggests that the
PCO thickness is a meaningful, and to the best of our
knowledge, previously unrecognized factor in decreased
VA. Future refinements of this technique will allow more
detailed investigation of other characteristics of PCO (with
resolutions 10 m), and new OCT software similar to the
retinal map software may be able to draw a full map of the
PCT.21 Preliminary analysis indicates that this is a valuable
tool in both clinical and research settings.
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